Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wells Fargo Downgrades Bank OZK to Equal-Weight, Lowers Price Target to $42

Wells Fargo analyst Jared Shaw downgrades Bank OZK (NASDAQ:OZK) from Overweight to Equal-Weight and lowers the price target from $58 to $42.
byBenzinga Newsdesk
July 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Wells Fargo analyst Jared Shaw downgrades Bank OZK (NASDAQ:OZK) from Overweight to Equal-Weight and lowers the price target from $58 to $42.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

SpringWorks’ Investigational Cancer Treatment Is Standard Care, Analyst Unfazed By FDA Update

By Vandana Singh
August 24, 2:35 PM
In March, the FDA issued SpringWorks Therapeutics Inc (NASDAQ: SWTX) with a Form 483 letter due to a failure to ensure that the analysis of an exploratory endpoint in the Phase 3 DeFi trial, which evaluated nirogacestat for the treatment of desmoid tumor (DT) patients that have experienced progres

SWTX